PCR Plastics 8strips domed caps only
- Known as:
- PCR test kit Plastics 8strips domed caps only
- Catalog number:
- FG-008DC
- Product Quantity:
- 120strips
- Category:
- -
- Supplier:
- nippon Genetics
- Gene target:
- PCR Plastics 8strips domed caps only
Related genes to: PCR Plastics 8strips domed caps only
- Gene:
- CAPS NIH gene
- Name:
- calcyphosine
- Previous symbol:
- -
- Synonyms:
- CAPS1, MGC126562
- Chromosome:
- 19p13.3
- Locus Type:
- gene with protein product
- Date approved:
- 1990-05-31
- Date modifiied:
- 2016-07-18
Related products to: PCR Plastics 8strips domed caps only
Related articles to: PCR Plastics 8strips domed caps only
- China's steel sector is pivotal to national and global climate goals, yet decarbonization is constrained by entrenched coal-based processes and regional disparities. Top-down and bottom-up models often neglect firm-level heterogeneity and behavioral dynamics. Here, we develop an agent-based model linking policy signals-carbon caps, pollution standards, and resource limits-with firm-level investment decisions. We evaluate four scenarios combining current and strengthened climate and air targets with neutral or accelerated technology progress. All scenarios achieve deep CO reductions (90 to 95% by 2060), but only the integrated policy-plus- technology pathway eliminates blast furnaces before midcentury, achieving the steepest declines. Policy- or technology-only pathways entail trade-offs, including lock-in to carbon capture and storage or delayed reductions. Our results show that synchronizing stringent climate policy with rapid technology cost declines is essential to steer China's steel industry toward a carbon-neutral trajectory. - Source: PubMed
Publication date: 2026/06/08
Liu XiaoDu JinhongLv LinglingHu JingnanLiu Xingang - Air medical and critical care transport teams often treat severely injured or critically ill patients when imaging, laboratory testing, and specialist support are limited. Point-of-care ultrasound (POCUS) may support early recognition of reversible conditions, but its value depends on strict indication selection, operator competence, and interpretation rules that prevent false reassurance. - Source: PubMed
Publication date: 2026/05/21
Chen LihuiLi JiajiaChen XiuxiuHuang JieLiang JialuQu ChenyingJin YalingYe YangtianCai MengqiChen Weiting - Medicare enrollment has shifted substantially toward Medicare Advantage (MA), rising from 33% in 2016 to over half of beneficiaries by 2025. While often interpreted as reflecting beneficiary preference, Medicare coverage choice is not neutral; policy design systematically advantages MA at the point of enrollment. Medicare's choice architecture concentrates salient financial protections and supplemental benefits within MA while deferring the consequences of managed care restrictions as future considerations, when switching options are limited. We identify 3 domains that create structural asymmetries between MA and Traditional Medicare (TM): affordability and benefit offerings, integrated plan design, and information and marketing. Together, these features make MA's advantages more visible at enrollment, through out-of-pocket caps, supplemental benefits, streamlined coverage, and third-party steering, while TM remains comparatively fragmented. We outline policy options to address these imbalances, including introducing an out-of-pocket cap in TM, expanding benefits, simplifying coverage design, improving decision and support tools, and strengthening oversight of marketing and brokerage practices. Leveling the playing field is not about steering beneficiaries toward TM or MA, but about ensuring that Medicare's growing reliance on enrollee choice rests on a foundation of comparability, transparency, and informed decision-making. - Source: PubMed
Publication date: 2026/05/14
Liu AngelaJouve Isabelle - - Source: PubMed
Publication date: 2026/05/21
Anderson David MShafer Paul R - - Source: PubMed
Publication date: 2026/06/06
Essien Utibe RByhoff Elena